Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Light Science Technologies, Ilika, Active Energy, Faron Pharmaceuticals, Solvonis Therapeutics, Coiled Therapeutics - Small Caps Week in Review

Light Science Technologies, Ilika, Active Energy, Faron Pharmaceuticals, Solvonis Therapeutics, Coiled Therapeutics - Small Caps Week in Review

Light Science Technologies Holdings PLC (AIM:LST, FRA:9FD) has acquired Injectaclad to expand further into the passive fire protection market. The patented graphite sealant helps stop fire spreading in buildings. CEO Simon Deacon described the deal as transformational. Watch more

Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A) has delivered its first commercial batch of Stereax electrodes to partner Cirtec Medical. The solid-state batteries are designed for tiny medical devices like implanted sensors and neurostimulators. Watch more

Active Energy Group PLC (AIM:AEG, OTCQB:ATGVF) plans to acquire a grid-connected site in Abu Dhabi for £2 million. The site already has power, meaning infrastructure could be installed in weeks rather than years. Watch more

Faron Pharmaceuticals Limited (AIM:FARN) announced a €40 million rights offering to fund development of its cancer drug bexmarilimab. The company is preparing a randomised phase II trial following encouraging earlier results. Watch more

Solvonis Therapeutics PLC (LSE:SVNS) has selected SVN-114 as the lead candidate in its PTSD discovery programme. The compound targets multiple brain systems linked to mood, behaviour and emotional processing. Watch more

Coiled Therapeutics (AIM:COIL) plans to list through a reverse takeover by Roquefort Therapeutics PLC. Funds from an £8.5 million raise will help advance its phase I cancer drug AO-252. Watch more

Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK